The Neoteric Paradigm of Biomolecule-Functionalized Albumin-Based Targeted Cancer Therapeutics

Area of Science:

• Biomaterials Science
• Nanotechnology
• Oncology

Background:

• Albumin, a natural protein, is a promising carrier for anticancer drugs, improving drug stability, solubility, circulation, and efficacy.
• Albumin nanoparticles exhibit biocompatibility, biodegradability, and passive tumor targeting via the enhanced permeability and retention effect.
• Non-specific drug accumulation in healthy tissues is a significant challenge in current cancer therapy.

Purpose of the Study:

• To review the functionalization of albumin nanoparticles with various biomolecules for targeted cancer therapy.
• To highlight the advantages of targeted albumin-based drug delivery systems.
• To discuss the potential of these advanced nanocarriers in improving clinical outcomes.

Main Methods:

• Review of literature on albumin nanoparticle functionalization strategies.
• Analysis of biomolecules used as ligands for albumin nanoparticle targeting (antibodies, nucleic acids, peptides, vitamins, etc.).
• Evaluation of the impact of functionalization on drug delivery, targeting specificity, and therapeutic efficacy.

Main Results:

• Functionalization of albumin nanoparticles with specific biomolecules enables targeted recognition and binding to cancer cells.
• Targeted albumin nanoparticles significantly improve tumor-specific drug delivery and minimize off-target effects.
• Enhanced cellular internalization and reduced side effects are observed with functionalized albumin nanocarriers.

Conclusions:

• Functionalized albumin nanoparticles represent a revolutionary approach to targeted tumor drug delivery.
• Biomolecule-guided albumin nanocarriers offer superior therapeutic efficacy, reduced toxicity, and improved clinical outcomes.
• Albumin-based nanocarriers, when functionalized with specific ligands, are a highly effective strategy for advanced cancer treatment.